Angiotensin 1-7 Completed Phase 2 Trials for Recurrent Uterine Sarcoma / Stage III Uterine Sarcoma / Metastatic Bone Sarcomas / Ovarian Sarcoma / Bone Cancer / Chondrosarcomas / Stage III Adult Soft Tissue Sarcoma / Stage IV Uterine Sarcoma / Recurrent Adult Soft Tissue Sarcoma / Recurrent Osteosarcoma / Stage IV Adult Soft Tissue Sarcoma / Clear Cell Sarcoma of the Kidney Treatment

Indications	Status	Purpose	Phase
DBCOND0028934 (Recurrent Uterine Sarcoma) DBCOND0030864 (Stage III Uterine Sarcoma) DBCOND0038791 (Metastatic Bone Sarcomas) DBCOND0028930 (Ovarian Sarcoma) DBCOND0029490 (Bone Cancer) DBCOND0036125 (Chondrosarcomas) DBCOND0028725 (Stage III Adult Soft Tissue Sarcoma) DBCOND0028933 (Stage IV Uterine Sarcoma) DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma) DBCOND0028757 (Recurrent Osteosarcoma) DBCOND0028932 (Stage IV Adult Soft Tissue Sarcoma) DBCOND0035409 (Clear Cell Sarcoma of the Kidney)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT01553539	Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery	Angiotensin 1-7 (DB11720) Angiotensin II (DB11842)